News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No major market-moving headlines were released in the past hour.
  • No scheduled economic data or central-bank announcements occurred during the past hour.
  • No significant corporate earnings, M&A filings, or IPOs were reported in the past hour.
  • No new geopolitical incidents or government policy shifts were reported in the past hour.
  • No material regulatory actions or legal rulings affecting markets were announced in the past hour.
  • News flow was light, leaving markets without fresh catalysts in the past hour.

Latest Articles

Sol-Gel Technologies Announces Last Patient Last Visit in Pivotal Phase 3 Clinical Trial of SGT-610 in Gorlin Syndrome

Sol-Gel Technologies Announces Last Patient Last Visit in Pivotal Phase 3 Clinical Trial of SGT-610 in Gorlin Syndrome

Sol-Gel Technologies announced that the last patient has completed the final visit in their pivotal Phase 3 clinical trial of SGT-610 (patidegib gel, 2%) for preventing basal cell carcinoma in Gorlin syndrome patients. The company will now finalize data analysis and expects to report top-line results by late November 2026. This milestone advances t…

Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress

Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress

Capricor Therapeutics announced it will present new 24-month data from the Phase 3 HOPE-3 study and open-label extension for Deramiocel, its lead allogeneic cell therapy for Duchenne muscular dystrophy (DMD), at the 2026 World Muscle Society Congress. The data show Deramiocel slows decline in upper limb function and supports both musculoskeletal an…

MIRA Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Following FDA Review

MIRA Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Following FDA Review

MIRA Pharmaceuticals announced the submission of its Phase 2a trial protocol for Ketamir-2, an oral NMDA receptor modulator, to evaluate efficacy and safety in patients suffering from chemotherapy-induced peripheral neuropathy (CIPN). Incorporating FDA recommendations, the study aims to initiate in early 2027 and marks Ketamir-2's first clinical ev…

Cavco Unveils Grande Arbor, First HUD-Code Manufactured Home Built Without a Steel Chassis, at 2026 Innovative Housing Showcase

Cavco Unveils Grande Arbor, First HUD-Code Manufactured Home Built Without a Steel Chassis, at 2026 Innovative Housing Showcase

Cavco Industries unveiled the Grande Arbor, the first HUD-code manufactured home built without a permanent steel chassis, at the 2026 Innovative Housing Showcase. This new construction method, enabled by recent legislation, allows for ground set homes offering improved aesthetics and design flexibility, including multistory options. The Grande Arbo…

Cabot Corporation to Expand North American Battery Materials Platform Through Modified $50 Million DOE Grant

Cabot Corporation to Expand North American Battery Materials Platform Through Modified $50 Million DOE Grant

Cabot Corporation announced a modified $50 million grant from the U.S. Department of Energy alongside $75 million in company investment to expand domestic production of advanced conductive battery materials at facilities in Louisiana and Texas. This expansion aims to meet increasing demand driven by energy storage growth, AI infrastructure power ne…

Saratoga Investment Corp. to Report Fiscal Second Quarter 2027 Financial Results and Hold Conference Call

Saratoga Investment Corp. to Report Fiscal Second Quarter 2027 Financial Results and Hold Conference Call

Saratoga Investment Corp., a US-based specialty finance company, announced it will report its fiscal Q2 2027 financial results on October 6, 2026, after market close, followed by a conference call on October 7 to discuss the results. The company primarily invests in leveraged loans and mezzanine debt targeting US middle-market businesses, and is ex…

Telomir Announces Peer-Reviewed Publication Showing Telomir-Zn Restores Visual Function and Retinal Structure in a Model of Age-Related Macular Degeneration (AMD)

Telomir Announces Peer-Reviewed Publication Showing Telomir-Zn Restores Visual Function and Retinal Structure in a Model of Age-Related Macular Degeneration (AMD)

Telomir Pharmaceuticals announced publication of peer-reviewed preclinical research demonstrating that Telomir-Zn significantly improves visual function, restores retinal structure, and reduces mitochondrial oxidative stress in an age-related macular degeneration (AMD) model. The findings reveal a novel epigenetic mechanism via intracellular metal …

TURBO ENERGY EXPANDS ITS C&I FOOTPRINT WITH A $3.5 MILLION PORTFOLIO OF 15 INTELLIGENT ENERGY STORAGE PROJECTS

TURBO ENERGY EXPANDS ITS C&I FOOTPRINT WITH A $3.5 MILLION PORTFOLIO OF 15 INTELLIGENT ENERGY STORAGE PROJECTS

Turbo Energy announces a $3.5 million firm-order portfolio comprising 15 intelligent energy storage projects totaling 15.6 MWh capacity and 5.95 MW power, expanding its footprint in commercial and industrial sectors in Spain and Chile. These projects highlight growing demand for AI-powered energy management systems amid global energy market volatil…

Worthington Enterprises Highlights Measurable Results  in 2026 Corporate Citizenship and Sustainability Report

Worthington Enterprises Highlights Measurable Results in 2026 Corporate Citizenship and Sustainability Report

Worthington Enterprises Inc. released its 2026 Corporate Citizenship and Sustainability Report highlighting measurable achievements in employee safety, engagement, environmental impact, and community investments. The company advanced its sustainability strategy focusing on people, planet, and prosperity with efforts in occupational safety, leadersh…

EVA DEFENSE UNVEILS NEXT-GENERATION LOW-NOISE AUTONOMOUS DRONE PROTOTYPE DESIGNED FOR STEALTH-ORIENTED OPERATIONS

EVA DEFENSE UNVEILS NEXT-GENERATION LOW-NOISE AUTONOMOUS DRONE PROTOTYPE DESIGNED FOR STEALTH-ORIENTED OPERATIONS

Eva Live Inc., through its subsidiary Eva Defense Inc., has unveiled a new low-noise autonomous drone prototype designed for stealth-oriented defense, intelligence, surveillance, and reconnaissance missions. The prototype emphasizes reduced acoustic signature and AI-enabled autonomy, aiming to integrate within an advanced ecosystem of unmanned airc…

Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma

Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma

Cingulate Inc., a biopharmaceutical company developing next-generation products using its proprietary Precision Timed Release™ platform, announced that its Chairman & CEO and Chief Commercial Officer will present at the Indegene Digital Summit, focusing on rethinking pharmaceutical commercialization for emerging pharma companies. The company is pre…